Company intelligence / Profile preview

WuXi Qinglan Biotechnology

Yixing, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

WuXi Qinglan provides gene synthesis services and DNA assembly capabilities supporting academic and commercial synthetic biology research, including large-scale synthetic genome projects.

Modalities: DNA synthesisSynthetic biology services
Industry: Non-Drug Biotech

Partnerships

Academic partnershipsWork on synthetic yeast chromosome projects

Beyond the preview

Go deeper on WuXi Qinglan Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WuXi Qinglan Biotechnology.

Explore the full profile